Some efficient strategies implemented by cancer cells to interfere with antigen presentation and activation of a cytotoxic T cell response includes the prevention of DC maturation, down-regulation of MHC molecules and the co-stimulatory receptors, inhibition of cytokine production, and induction of inhibitory receptor expression [14]. This evidence concerns the gene HLA-C and cancer.